Announcements Trials
Browse Landscape

Status

Withdrawn 1Unknown 1Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Observational 5

Sponsor

Cancer Type

Tumor-Agnostic 2Other hematologic neoplasm 1CNS 1

Conditions

Neoplasms 5Polycythemia Vera 4Lung Neoplasms 4Ovarian Neoplasms 3Myeloproliferative Disorders 3Colorectal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Breast Neoplasms 3Prostatic Neoplasms 2Lymphoma 2Head and Neck Neoplasms 2Carcinoma, Squamous Cell 2Brain Neoplasms 2Adenocarcinoma 2Urticaria 1Tuberous Sclerosis 1Thymic aplasia 1Thrombosis 1Squamous Cell Carcinoma of Head and Neck 1Smoking 1Small Cell Lung Carcinoma 1Severe Combined Immunodeficiency 1Sarcoma 1Salivary Gland Neoplasms 1Renal Insufficiency, Chronic 1Rectal Neoplasms 1Primary Dysautonomias 1Polycythemia 1Polycystic Ovary Syndrome 1Pancreatitis, Chronic 1

Interventions

pembrolizumab 185Gemcitabine 170Paclitaxel 152Carboplatin 137Bevacizumab 128Surveys and Questionnaires 118Cisplatin 115Docetaxel 114Blood Specimen Collection 110Cyclophosphamide 109Exercise 108Nivolumab 98Fluorouracil 90Capecitabine 86Dexamethasone 81Radiotherapy 80Irinotecan 74Standard of Care 69Pemetrexed 68Oxaliplatin 68Leucovorin 64Drug Therapy 64Cetuximab 60Erlotinib Hydrochloride 56Sorafenib 53atezolizumab 52Ipilimumab 51Doxorubicin 50trametinib 47Interviews as Topic 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Neoplasms × Phlebotomy × Clear all
NCT07121998 2025-08-14

PROGRESS-TMZ

Uppsala University

Recruiting
94 enrolled

Endocrine Gland Neoplasms, Neoplasms

NCT00695279 2024-10-30

Long Term Follow Up Of Patients Who Have Received Gene Therapy Or Gene Marked Products

St. Jude Children's Research Hospital

Completed
41 enrolled
CNSOther hematologic neoplasm

Mucopolysaccharidosis I, Neoplasms, Neuroblastoma, Severe Combined Immunodeficiency, Hematologic Neoplasms

NCT03884400 2022-11-14

Distribution of Biospecimens From Biorepositories/Biobanks for Research Use

iSpecimen Inc

Withdrawn

Autoimmune Diseases, Digestive System Diseases, Neoplasms, Nephritis

NCT00507702 2019-04-18

Identification of Key Blood Molecular Markers for Immunotherapy

Stanford University

Terminated
191 enrolled
Tumor-Agnostic

Adenocarcinoma, Carcinoma, Squamous Cell, Neoplasms

NCT02874729 2016-11-25

Assay Development for Cancer Biomarkers

King's College London

Unknown
400 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡